Claritas Pharmaceuticals, Inc. Stock
Stocks
CLAZF
CA1806342061
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | -.--% |
|
-.--% | - |
| Market Cap | 5.37M 3.82M 3.32M 3.1M 2.85M 364M 5.46M 36.57M 14.32M 182M 14.36M 14.04M 599M | P/E 2019 |
-0.74x | P/E 2020 | 0.13x |
|---|---|---|---|---|---|
| Enterprise Value | 6.29M 4.48M 3.89M 3.63M 3.34M 427M 6.4M 42.84M 16.78M 213M 16.82M 16.45M 702M | EV / Sales 2019 |
-
| EV / Sales 2020 | - |
| Free-Float |
99.74% | Yield 2019 * |
-
| Yield 2020 | - |
| 3 years | 0 |  | 0 |
| 5 years | 0 | | 0.42 |
| 10 years | 0 | | 15.31 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Farrell
CEO | Chief Executive Officer | 76 | 2017-06-20 |
Victoria Rudman
DFI | Director of Finance/CFO | 58 | 2018-06-28 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Farrell
CHM | Chairman | 76 | 2021-03-17 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 10/11/21 | Buy | 118,000 | 0.3332% | |||
| 10/11/21 | Buy | 152,500 | 0.4307% | |||
| 10/11/21 | Buy | 24,500 | 0.0692% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 37 | |
| -0.36% | +0.14% | -2.06% | +14.33% | 48.22B | |
| -2.71% | -2.99% | +398.09% | +472.12% | 38.79B | |
| -0.71% | +9.45% | +27.90% | +7.89% | 38.41B | |
| -0.71% | -3.72% | +4.94% | +52.45% | 34.88B | |
| -2.41% | +1.96% | +11.68% | +38.17% | 29.19B | |
| -0.66% | -2.73% | +35.50% | +122.17% | 16B | |
| -0.19% | -3.93% | - | - | 16.05B | |
| -0.62% | +1.23% | +2.76% | +15.05% | 13.53B | |
| -3.15% | -6.14% | -4.82% | -36.90% | 12.22B | |
| Average | -1.15% | -0.60% | +59.25% | +85.66% | 24.73B | |
| Weighted average by Cap. | -1.23% | +0.15% | +75.56% | +103.60% |
| 2019 | 2020 | |
|---|---|---|
| Net sales | - | - |
| Net income | -21.21M -15.1M -13.13M -12.25M -11.25M -1.44B -21.58M -144M -56.59M -718M -56.73M -55.47M -2.37B | 4.21M 3M 2.61M 2.43M 2.23M 286M 4.28M 28.68M 11.23M 142M 11.26M 11.01M 470M |
| Net Debt | 704K 501K 436K 407K 373K 47.78M 716K 4.8M 1.88M 23.83M 1.88M 1.84M 78.58M | 920K 655K 569K 531K 488K 62.43M 936K 6.27M 2.45M 31.14M 2.46M 2.41M 103M |
Employees
-
- Stock Market
- Stocks
- CLAZF Stock
Select your edition
All financial news and data tailored to specific country editions
